| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 76.713 | 87.425 | 87.523 | 75.789 | 84.563 | 60.031 | 75.500 | 98.581 | 121.135 | 63.653 |
| Total Income - EUR | 76.905 | 87.651 | 87.541 | 75.814 | 84.667 | 60.084 | 75.526 | 98.723 | 121.152 | 63.710 |
| Total Expenses - EUR | 46.590 | 54.611 | 69.002 | 70.611 | 83.080 | 48.783 | 48.013 | 82.989 | 100.198 | 70.766 |
| Gross Profit/Loss - EUR | 30.315 | 33.040 | 18.539 | 5.203 | 1.588 | 11.301 | 27.514 | 15.733 | 20.954 | -7.056 |
| Net Profit/Loss - EUR | 25.275 | 31.287 | 17.664 | 4.445 | 742 | 10.738 | 26.849 | 14.747 | 19.767 | -7.934 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alpha Hipomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.524 | 9.949 | 6.949 | 4.926 | 2.917 | 1.468 | 908 | 696 | 1.863 | 1.407 |
| Current Assets | 46.325 | 40.660 | 68.012 | 70.416 | 86.043 | 97.739 | 86.962 | 77.793 | 84.174 | 45.148 |
| Inventories | 2.987 | 21.514 | 23.979 | 23.509 | 16.875 | 19.512 | 20.921 | 20.800 | 21.034 | 19.535 |
| Receivables | 28.070 | 11.142 | 12.122 | 44.090 | 50.511 | 38.488 | 47.179 | 48.205 | 47.915 | 21.237 |
| Cash | 15.269 | 8.004 | 31.911 | 2.817 | 18.656 | 39.739 | 18.863 | 8.788 | 15.225 | 4.377 |
| Shareholders Funds | 25.370 | 31.340 | 48.474 | 42.579 | 42.496 | 52.429 | 78.115 | -8.325 | 11.468 | 3.469 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.601 | 19.583 | 26.760 | 33.008 | 46.674 | 46.913 | 9.920 | 86.956 | 74.749 | 43.329 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Alpha Hipomed Srl